Skip to main content

Table 1 Characteristics of primers used for qPCR

From: Carnitine supplementation to obese Zucker rats prevents obesity-induced type I to type II muscle fiber transition and favors an oxidative phenotype of skeletal muscle

Gene symbol

Primer sequence (forward, reverse; from 5′ to 3′)

NCBI GeneBank

Product size (bp)

Slope

R2#

Efficiency*

(HUGO)

ACADL

AAGGATTTATTAAGGGCAAGAAGC

NM_012819

380 bp

-3.88

0.998

1.81

GGAAGCGGAGGCGGAGTC

ACADM

CAAGAGAGCCTGGGAACTTG

NM_016986

154 bp

-3.38

0.999

1.98

CCCCAAAGAATTTGCTTCAA

ATP5B

GCACCGTCAGAACTATTGCT

NM_134364

203 bp

-3.59

0.999

1.90

GAATTCAGGAGCCTCAGCAT

CANX

CCAGATGCAGATCTGAAGAC

NM_172008

175 bp

-2.75

0.999

2.31

CTGGGTCCTCAATTTCACGT

CD36

TCGTATGGTGTGCTGGACAT

NM_031561

358 bp

-3.28

0.996

2.02

GGCCCAGGAGCTTTATTTTC

CPT1B

GCAAACTGGACCGAGAAGAG

NM_013200

180 bp

-3.32

0.988

2.00

CCTTGAAGAAGCGACCTTTG

FABP3

ACCATCCACTGCCGTCTTAC

NM_013177

310 bp

-3.20

0.957

2.05

CCCCGATGCGTAGGTATTCT

HK2

GATGGAATCGAGAAGGCCTA,

NM_012735

220 bp

-3.63

1.000

1.89

GTTTCTTGTAGACGGAGCCA

LPL

GAGATTTCTCTGTATGGCACA

NM_012598

276 bp

-3.34

0.992

1.99

CTGCAGATGAGAAACTTTCTC

MDH1

CAGACAAAGAAGAGGTTGCC,

NM_033235

206 bp

-3.40

0.994

1.97

CGTCAGGCAGTTTGTATTGG

MYH1

GCAGACTCTCCCACTGGGCTG

NM_001135158

83 bp

-3.16

0.953

2.07

GAGCAGCCTCCCCGAAAACGG

MYH2

GCTGATCGAAATGCTGCTGA

NM_001135157

124 bp

-3.38

0.990

1.98

GTCAATAGCACTATCCGTGG

MYH4

CCAGTCCATCCTGATTACTG

NM_019325

74 bp

-3.48

0.988

1.94

CAAAGTACTGGATGACACGC

MYH7

ATTGCCGAGTCCCAGGTCAACA

NM_017240

127 bp

-3.24

0.944

2.03

GCTCCAGGTCTCAGGGCTTCAC

PFKM

TCCTGGTTGGCTCAATCGAC

NM_031715

297 bp

-3.75

0.998

1.85

TGTTGAGACGAGAACCACGG

PKM

ACCTGGGCATTGAGATTCCG

NM_053297

314 bp

-3.69

0.997

1.87

TCGCGCAAGCTCTTCAAACA

PPARD

GCAGAGCTATGACCAGGCCTGCA

NM_013141

151 bp

-3.29

0.990

2.01

GTGCTCTGGTCCCCCGTTGA

PPARGC1A

CTCTTTGCCCAGATCTTCCT

NM_031347

145 bp

-3.93

0.999

1.80

ATGTTCGCGGGCTCATTGTT

PPARGC1B

CATATAAGCCCATGGAGGAG

NM_176075

476 bp

-3.25

0.978

2.03

CAGCCCAAAGTGCTTTGTGA

RPL13

CTTAAATTGGCCACGCAGCT

XR_086310

198 bp

-3.48

0.998

1.94

CTTCTCAACGTCTTGCTCTG

SDHA

TGGACCTTGTCGTCTTTGG

NM_130428

88 bp

-3.90

0.997

1.80

TTTGCCTTAATCGGAGGAAC

SLC2A4

GAGTTATGTGTCCATCGTGG

NM_012751

187 bp

-2.59

0.953

2.40

CGCAACATACTGGAAACCCA

SLC22A5

GAACTCACGAGCCTCGCACGC

NM_019269

117 bp

-3.75

0.997

1.85

TCGTCGTAGTCCCGCATGCC

SLC25A20

AGCCCACCTGTTATCCACTG

NM_053965

178 bp

-3.32

0.988

2.00

TGTGCAAAAAGAGCCTTCCT

SLC27A1

GTATCTGCTGGACCTTCGC

NM_053580

243 bp

-3.48

0.990

1.94

CATAAATGAGGGCCTTGGCA

TOP1

GAAGAACGCTATCCAGAAGG

NM_022615

137 bp

-3.33

0.997

2.00

GCTTTGGGACTCAGCTTCAT

UCP1

CAGGCTTCCAGTACTATTAGG

NM_012682

181 bp

-3.40

0.983

1.97

CTCTCCCTGAAGAGAAGTACT

UCP2

CAAGGAGAGAGTCAAGGGCTA

NM_019354

209 bp

-3.08

0.998

2.11

GACTCTGAGCCCTTGGTGTAG

UCP3

CTCGGTACCATCCTGACTAT

NM_013167

149 bp

-3.47

0.982

1.94

GTTCCTTTGGGGGTGTAGAA

VEGFA

GTTCATGGACGTCTACCAGC

NM_031836

253 bp

-3.62

0.973

1.89

GCTATGCTGCAGGAAGCTCA

VEGFB

GTGTCCCAGTTTGATGGCC

NM_053549

187 bp

-3.45

1.000

1.95

CGTCAGGACAGCAGCCAC

YWHAZ

GACGGAAGGTGCTGAGAAA

NM_013011

198 bp

-3.13

0.986

2.09

GCAGCAACCTCAGCCAAGT

  1. #Coefficient of determination of the standard curve.
  2. *The efficiency is determined by [10(-1/-slope].